Most scenarios correspond to reductions in cumulative TB incidence when assumptions about durability of protection on ART are optimistic, and for earlier CD4 thresholds for ART initiation (see Figure S5 in Materials S1). This evidence concerns the gene CD4 and tuberculosis.